Other
Cd Private Equity Fund Iii (CD3)
Cd Private Equity Fund Iii (CD3) is an ASX-listed investment company (LIC) providing public market investors access to a diversified portfolio of global private equity funds and direct co-investments. Its primary objective is to generate long-term capital appreciation by investing in unlisted companies across various sectors and geographies, aiming to capitalise on private market growth opportunities.
Market Cap
A$68M
Shares on Issue
N/A
Price Chart
AI Analysis
As a micro-cap LIC with a market cap of A$75M, CD3's performance is intrinsically linked to the valuation and liquidity events within its underlying private equity portfolio. Recent performance would largely reflect fluctuations in its Net Asset Value (NAV) per share, driven by revaluations of its unlisted holdings, successful (or unsuccessful) exits, and currency movements given its global exposure. The share price often trades at a discount or premium to its reported NAV, influenced by broader market sentiment towards illiquid assets and investor confidence in management's ability to generate returns.
The growth outlook for CD3 hinges on its ability to identify and invest in high-performing private companies and funds, alongside successful capital recycling through timely exits. Upcoming catalysts could include significant divestments from its portfolio generating substantial realised gains, new strategic investments, or capital management initiatives aimed at reducing the NAV discount. The strategic direction involves active portfolio management, prudent capital deployment, and potentially adjusting its allocation mix to optimise returns in evolving private equity markets.
Bull Case
- • Strong performance from underlying private equity investments, leading to significant increases in the Net Asset Value (NAV) per share.
- • Successful exits (e.g., IPOs, trade sales) of portfolio companies at premium valuations, generating substantial realised gains and potential distributions to shareholders.
- • A narrowing or elimination of the discount between CD3's share price and its underlying NAV, reflecting increased investor confidence and market recognition of value.
Bear Case
- • Underperformance or write-downs in a significant portion of the underlying private equity portfolio, leading to a decrease in NAV per share.
- • Economic downturns or adverse market conditions impacting private company valuations, making successful exits difficult or forcing sales at lower-than-expected prices.
- • Persistent or widening discount between the share price and NAV, reflecting ongoing investor concerns about liquidity, valuation transparency, or management's ability to deliver returns.
Recent Announcements
Quarterly Activities Report
Highlights production updates, capital allocation priorities, and FY guidance commentary.
Investor Presentation
Strategic outlook with market positioning and growth pipeline.
FAQs
What does CD3 do?
Cd Private Equity Fund Iii (CD3) is an ASX-listed investment company that provides retail and institutional investors with access to a diversified portfolio of private equity investments, including fund-of-funds and direct co-investments in unlisted companies globally.
Is CD3 a good investment?
Investing in CD3 offers exposure to private equity growth potential, but it comes with inherent risks like illiquidity of underlying assets, valuation subjectivity, and potential for a persistent discount to NAV. As a micro-cap, it carries a higher speculative element, making it suitable for investors with a long-term horizon and tolerance for volatility.
What drives CD3's share price?
CD3's share price is primarily driven by changes in its Net Asset Value (NAV) per share, which reflects the performance of its underlying private equity portfolio. Other key factors include market sentiment towards private assets, successful exits or new investments, distributions paid, and the prevailing discount or premium to its reported NAV.
Key Metrics
Related Stocks
Other
ACQAcorn Capital Investment Fund Limited
A$0.95
30.1% 1Y
Acorn Capital Investment Fund Limited (ACQ) is an ASX-listed investment company (LIC) managed by specialist microcap investor Acorn Capital. The fund provides investors with access to a diversified portfolio of emerging Australian micro and small-cap companies, including both listed and unlisted entities. Its investment strategy focuses on identifying early-stage, high-growth potential businesses across various sectors.
Other
AFIAustralian Foundation Investment Company Limited
A$6.79
-4.1% 1Y
Australian Foundation Investment Company Limited (AFI) is a closed-end diversified investment trust operating solely in Australia, focusing on investing in a portfolio of mainly ASX-listed shares to provide long-term returns to shareholders through a combination of dividends and capital growth. Key holdings historically include blue-chip Australian stocks across various sectors. AFI is managed by Australian Foundation Investment Company Ltd itself, emphasizing a conservative investment approach.
Other
AIQAlternative Investment Trust
A$1.45
-1.9% 1Y
Alternative Investment Trust (ASX: AIQ) is a listed investment trust (LIT) on the Australian Securities Exchange. It provides investors with exposure to a diversified portfolio of alternative assets, primarily through investments in a global diversified portfolio of hedge funds. The trust aims to generate long-term capital growth and income for its unitholders by accessing investment strategies not typically available to retail investors.